These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 19594426)
1. The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Myler PJ; Stacy R; Stewart L; Staker BL; Van Voorhis WC; Varani G; Buchko GW Infect Disord Drug Targets; 2009 Nov; 9(5):493-506. PubMed ID: 19594426 [TBL] [Abstract][Full Text] [Related]
2. Structural genomics of infectious disease drug targets: the SSGCID. Stacy R; Begley DW; Phan I; Staker BL; Van Voorhis WC; Varani G; Buchko GW; Stewart LJ; Myler PJ Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Sep; 67(Pt 9):979-84. PubMed ID: 21904037 [TBL] [Abstract][Full Text] [Related]
3. Fragment screening of infectious disease targets in a structural genomics environment. Begley DW; Davies DR; Hartley RC; Edwards TE; Staker BL; Van Voorhis WC; Myler PJ; Stewart LJ Methods Enzymol; 2011; 493():533-56. PubMed ID: 21371605 [TBL] [Abstract][Full Text] [Related]
4. Structural genomics and drug discovery for infectious diseases. Anderson WF Infect Disord Drug Targets; 2009 Nov; 9(5):507-17. PubMed ID: 19860716 [TBL] [Abstract][Full Text] [Related]
5. Gene design, cloning and protein-expression methods for high-value targets at the Seattle Structural Genomics Center for Infectious Disease. Raymond A; Haffner T; Ng N; Lorimer D; Staker B; Stewart L Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Sep; 67(Pt 9):992-7. PubMed ID: 21904039 [TBL] [Abstract][Full Text] [Related]
6. Target selection for structural genomics: an overview. Marsden RL; Orengo CA Methods Mol Biol; 2008; 426():3-25. PubMed ID: 18542854 [TBL] [Abstract][Full Text] [Related]
7. High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease. Bryan CM; Bhandari J; Napuli AJ; Leibly DJ; Choi R; Kelley A; Van Voorhis WC; Edwards TE; Stewart LJ Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Sep; 67(Pt 9):1010-4. PubMed ID: 21904042 [TBL] [Abstract][Full Text] [Related]
8. Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba. Tillery L; Barrett K; Goldstein J; Lassner JW; Osterhout B; Tran NL; Xu L; Young RM; Craig J; Chun I; Dranow DM; Abendroth J; Delker SL; Davies DR; Mayclin SJ; Calhoun B; Bolejack MJ; Staker B; Subramanian S; Phan I; Lorimer DD; Myler PJ; Edwards TE; Kyle DE; Rice CA; Morris JC; Leahy JW; Manetsch R; Barrett LK; Smith CL; Van Voorhis WC PLoS One; 2021; 16(3):e0241738. PubMed ID: 33760815 [TBL] [Abstract][Full Text] [Related]
10. The tuberculosis structural genomics consortium: a structural genomics approach to drug discovery. Musa TL; Ioerger TR; Sacchettini JC Adv Protein Chem Struct Biol; 2009; 77():41-76. PubMed ID: 20663481 [TBL] [Abstract][Full Text] [Related]
11. A new asset for pathogen informatics--the Enteropathogen Resource Integration Center (ERIC), an NIAID Bioinformatics Resource Center for Biodefense and Emerging/Re-emerging Infectious Disease. Greene JM; Plunkett G; Burland V; Glasner J; Cabot E; Anderson B; Neeno-Eckwall E; Qiu Y; Mau B; Rusch M; Liss P; Hampton T; Pot D; Shaker M; Shaull L; Shetty P; Shi C; Whitmore J; Wong M; Zaremba S; Blattner FR; Perna NT Adv Exp Med Biol; 2007; 603():28-42. PubMed ID: 17966403 [TBL] [Abstract][Full Text] [Related]
12. Benefits of structural genomics for drug discovery research. Grabowski M; Chruszcz M; Zimmerman MD; Kirillova O; Minor W Infect Disord Drug Targets; 2009 Nov; 9(5):459-74. PubMed ID: 19594422 [TBL] [Abstract][Full Text] [Related]
13. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery. Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096 [TBL] [Abstract][Full Text] [Related]
14. Combating Diseases with Computational Strategies Used for Drug Design and Discovery. Makhouri FR; Ghasemi JB Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568 [TBL] [Abstract][Full Text] [Related]
15. The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins. Gileadi O; Knapp S; Lee WH; Marsden BD; Müller S; Niesen FH; Kavanagh KL; Ball LJ; von Delft F; Doyle DA; Oppermann UC; Sundström M J Struct Funct Genomics; 2007 Sep; 8(2-3):107-19. PubMed ID: 17932789 [TBL] [Abstract][Full Text] [Related]
16. Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases. NIH, DMID TB program Tuberculosis (Edinb); 2013 Jan; 93(1):6-11. PubMed ID: 23385001 [TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]